CTX211

Trademark usage description

cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of diabetes; gene therapy products, namely, gene tran Read More

Classification Information

Class [005]
Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of diabetes; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of diabetes

Classification kind code

Class [042]
Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders; gene editing, namely, pharmaceutical research and development

Classification kind code

Mark Details

Serial Number

2306108

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 287 on 1^st Feb 2024	Pre-Assessment Letter Sent
Submitted for opposition 30 on 22^nd Jan 2024	Filed
Submitted for opposition 1 on 22^nd Jan 2024	Created
Submitted for opposition 31 on 22^nd Jan 2024	Formalized

CTX211

Classification Information

Class [005]Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of diabetes; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of diabetes

Classification kind code

Class [042]Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders; gene editing, namely, pharmaceutical research and development

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [005]
Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of diabetes; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of diabetes

Class [042]
Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders; gene editing, namely, pharmaceutical research and development